May 28, 2025 / 10:00AM GMT
Andrew Newland - Angle PLC - Chief Executive, Executive Director
Good morning everybody and welcome to Angle's preliminary presentation for 2024. I'm pleased to see a very good turnout, considering it's half term, in the FTI offices, and a warm welcome to those of you who are participating virtually.
It's been a year of substantial progress for Angle in a market that is moving towards us, and I'm looking forward to telling you about the progress that has been made. Our large pharma strategy is now in place. We announced that in the middle of last year. It's firmly in place and it's moving forward well.
This is all about using pastortics to select and monitor patients in trials for pharmaceutical drug development, and that can progress all the way through to companion diagnostics, where the pastortic system could be used to select patients for each drug.
This approach is critical to the new way that drugs are being developed for precision medicine. The new cancer drugs only work for some patients, and it's critical to work out which patients. These kinds of new drugs, such as
Full Year 2024 Angle PLC Earnings Call Transcript
May 28, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers